Rare (and Rarely Diagnosed) Diseases in Ophthalmology - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Rare (and Rarely Diagnosed) Diseases in Ophthalmology

Regulatory policies, combined with better screening tools, can broaden access to needed treatments

  • By

  • Neel Desai

  • January 21, 2026

  • 8 min

Share

Objective:

Emphasize the significance of the Orphan Drug Act in the context of rare diseases.

Key Findings:
  • Add a finding about the necessity of clinician education to combat underdiagnosis.
Interpretation:

Strengthen the urgency of addressing barriers to treatment.

Limitations:
  • Include the impact of high drug costs on patient access.
Conclusion:

Stress the importance of collaboration among stakeholders to enhance patient outcomes.

Original Source(s)

Rare (and Rarely Diagnosed) Diseases in Ophthalmology

  • by Neel Desai

  • January 21, 2026

Related Content

Industry Pros Honored With GSLS Awards

The 2026 recipients of the Global Specialty Lens Symposium (GSLS) Awards were honored on January 8 at the annual meeting in Las Vegas. Patrick Caroline received the Award of Excellence, and Maria K. Walker, OD, PhD, received the Rising Star Award.

Case Report: Effective management of acute corneal hydrops with concurrent nystagmus and retinitis pigmentosa: combination of deep lamellar corneal suturing and anterior chamber gas injection

Online Photo Diagnosis

A case study illustrates how advancements in specialty lens design can restore functional vision in keratoconus patients.